We invested in List Partners, a a provider of sales intelligence content used by business development professionals who target national advertisers and their agencies across the U.S. and the U.K.
We invested in SmartWave Technologies, a market-leading manufacturer of innovative electronic and electromechanical systems for a broad range of end markets, including the away-from-home restroom market. Founded in 1994, SmartWave designs components for products that require sensing, verifying, or dispensing on behalf of companies in the healthcare, hygiene, sanitary, plumbing supply and other end markets. SmartWave adds value to customers' products by incorporating technology that improves the product functionality and enhances the end user experience.
Linden Capital Partners and Northlane Capital Partners completed the merger of their portfolio companies Chesapeake IRB and Schulman IRB, respectively, to create Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), and research compliance services in North America.
We invested in PAR Excellence Systems, a market leader in specialized supply chain management systems for the healthcare industry. Headquartered in Cincinnati, OH, PAR Excellence Systems offers comprehensive inventory management systems and related support services that enable healthcare organizations to fully automate inventory replenishment activities and generate real-time, system-wide inventory visibility. The systems also simplify the caregivers’ day-to-day tasks and allow them to focus on their core objective of patient care.
We announced our spinout from American Capital, Ltd. in connection with Ares Capital Corporation’s (Nasdaq: ARCC) acquisition of American Capital effective January 3, 2017.
Brandmuscle, an NCP portfolio company, made an investment in Saepio Technologies, a provider of marketing management software. Saepio Technologies complements Brandmuscle’s current local marketing offerings to create the largest and most comprehensive suite of software and services to support global brands that sell through distributed networks of dealers, agents and franchisees.
We invested in Brandmuscle, a leading provider of local marketing automation technology and services. Headquartered in Chicago and with offices in Cleveland, Austin and New Jersey, Brandmuscle provides software and services that enable brands with distributed sales and marketing channels to easily create and execute brand-compliant, local marketing campaigns across all mediums and formats. Brandmuscle employs more than 650 professionals and serves more than 200 of the world's leading brands.
Mirion Technologies, Inc. (“Mirion”) was sold to Charterhouse Capital Partners, LLP for $750 million. Mirion is a global provider of radiation detection, measurement, analysis and monitoring products and services to the nuclear power, medical, military and homeland security markets. Mirion was created in December 2005 through the merger of three companies: synOdys, Global Dosimetry Solutions (GDS) and Imaging and Sensing Technology (IST). Headquartered in San Ramon, CA, Mirion has 13 facilities across North America, Europe and Asia and employs more than 1,000 people.
We invested in Schulman IRB, a leading independent Institutional Review Board ("IRB") that provides clinical trial oversight services to pharmaceutical firms, contract research organizations, hospitals and academic medical centers throughout the United States and Canada. Founded in 1983 and based in Cincinnati, Ohio, Schulman IRB is one of the largest IRBs in the United States. The Company primarily serves the pharmaceutical and medical device industries as a central IRB on research involving drugs, medical devices and biologics. Schulman reviews research protocols and consent documents from clinical trials to evaluate compliance with human subject protection regulations. Schulman is fully accredited by the Association for the Accreditation of Human Research Protection Programs.
Avalon Laboratories ("Avalon" or the "Company) was sold to Nordson Corporation (Nasdaq: NDSN), the world's leading precision fluid dispensing systems manufacturer, for $180 million. Avalon is a leading designer and manufacturer of highly-specialized, single-use catheters and specialty medical tubing products for cardiology, pulmonology and related applications. Avalon's devices are life-critical components that provide connections between patients and life support machines. The Company serves OEM customers in the cardiology, pulmonology, endovascular, bariatrics, tracheostomy, endoscopy, non-vascular stent and ophthalmic markets segments. Avalon is headquartered in Los Angeles, CA and has a FDA and ISO 13485 registered manufacturing facility in Guaymas, Mexico.
The fund’s LPs include sovereign wealth funds, state retirement and pension systems, high net worth family offices, superannuation funds and foundations, and former portfolio company CEOs. The fund will focus on investments in companies with EBITDA of at least $5 million. As part of the closing, the fund acquired equity stakes from ACAS in eight companies: Mirion Technologies, SMG, Affordable Care, WRH, Potpourri, Avalon, FAMS and CIBT.